FindTrial
Sign In

Healthcare costs of inflammatory bowel disease in Korea

Trends in healthcare costs and utilization for inflammatory bowel disease in Korea from 2006 to 2015 : a Nationwide Population-Based Study Using the Korean National Health Insurance System.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0003326
Enrollment
250000
Registered
2018-11-08
Start date
2018-07-02
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Kyung Hee University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients given a primary diagnosis of inflammatory bowel disease 2. Patients who had been prescribed IBD-related drugs.

Exclusion criteria

Exclusion criteria: Patients who had not been prescribed IBD-related drugs

Design outcomes

Primary

MeasureTime frame
inflammatory bowel disease related cost profiles—

Secondary

MeasureTime frame
demographic characteristics of patients with high inflammatory bowel disease related costs—

Countries

Korea, Republic of

Contacts

Public ContactJung-Wook Kim

Kyung Hee University Hospital

iloveact@hanmail.net+82-2-958-8141

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026